2023
DOI: 10.3390/ijms24010865
|View full text |Cite
|
Sign up to set email alerts
|

The Inhibitory Properties of a Novel, Selective LMTK3 Kinase Inhibitor

Abstract: Recently, the oncogenic role of lemur tyrosine kinase 3 (LMTK3) has been well established in different tumor types, highlighting it as a viable therapeutic target. In the present study, using in vitro and cell-based assays coupled with biophysical analyses, we identify a highly selective small molecule LMTK3 inhibitor, namely C36. Biochemical/biophysical and cellular studies revealed that C36 displays a high in vitro selectivity profile and provides notable therapeutic effect when tested in the National Cancer… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
4
1

Relationship

2
3

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 40 publications
0
3
0
Order By: Relevance
“…Significantly high levels of phosphorylation were seen for serine 232 (S232), the phosphorylation of which has been shown to be critical for the catalytic activity of LMTK3. 22 , 23 , 35 In addition to S232, LMTK3 was phosphorylated on 12 other amino acids, but the significance of these covalent modifications for its activity, membrane trafficking, or stability is unknown.…”
Section: Resultsmentioning
confidence: 99%
“…Significantly high levels of phosphorylation were seen for serine 232 (S232), the phosphorylation of which has been shown to be critical for the catalytic activity of LMTK3. 22 , 23 , 35 In addition to S232, LMTK3 was phosphorylated on 12 other amino acids, but the significance of these covalent modifications for its activity, membrane trafficking, or stability is unknown.…”
Section: Resultsmentioning
confidence: 99%
“…Cell Death and Apoptosis: The assay was performed as previously described. [63,64] Cells were transfected with either siCTRL or siPANK4 as described above and subjected to drug treatments as specified in the corresponding figures and figure legends. After 96 h, cells were stained using the Muse Annexin V Dead Cell Kit according to the manufacturer's instructions (Luminex, #MCH100105).…”
Section: Methodsmentioning
confidence: 99%
“…A range of biophysical techniques and cell-based assays were used to identify a highly selective small molecule inhibitor of lemur tyrosine kinase 3 (LMTK3), which is a dual specificity serine/threonine kinase with an oncogenic role in various tumour types and a viable therapeutic target. The analyses included use of MST to obtain binding curves for the new inhibitor C36 (KD = 1.87 ± 0.2 µM) and an existing inhibitor C28 (KD = 2.50 ± 0.4 µM) with human LMTK3 [56].…”
Section: Sensor Kinasesmentioning
confidence: 99%